Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04543773 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Individualized Targeting and Neuromodulation of Late-Life Depression

Study acronym: TMS-LLD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later across 2 updates Jul 1, 2026 → Nov 1, 2026
See other at-risk trials from University of New Mexico

Record History

  1. Primary completion pushed from Sep 1, 2026 to Nov 1, 2026 Completion pushed from Sep 1, 2026 to Sep 1, 2027 · Eligibility criteria expanded, about 17 words · Study description revised Show 3 more changesShow less
    • Completion pushed from Sep 1, 2026 to Sep 1, 2027
    • Eligibility criteria expanded, about 17 words
    • Study description revised
  2. Primary and study completion pushed from Jul 1, 2026 to Sep 1, 2026v9
  3. Primary completion date: Dec 1, 2025 to Jul 1, 2026 Trial status: Recruiting to Active, Not Recruiting · Completion date: Dec 31, 2025 to Jul 1, 2026 · Site details revisedv8 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Dec 31, 2025 to Jul 1, 2026
    • Site details revised
  4. Primary completion date: Dec 1, 2024 to Dec 1, 2025 Start date: Oct 1, 2020 to Oct 1, 2024v7 Show 1 more changeShow less
    • Start date: Oct 1, 2020 to Oct 1, 2024
  5. Primary completion date: Dec 31, 2023 to Dec 1, 2024 Completion date: Dec 31, 2023 to Dec 31, 2025v6 Show 1 more changeShow less
    • Completion date: Dec 31, 2023 to Dec 31, 2025
Show 4 earlier versionsHide 4 earlier versions
  1. Primary and study completion dates: Oct 30, 2023 to Dec 31, 2023v5
  2. Primary and study completion dates: Apr 30, 2023 to Oct 30, 2023v4
  3. Primary and study completion dates: Oct 30, 2021 to Apr 30, 2023v3
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary and study completion dates: Jun 30, 2021 to Oct 30, 2021v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Primary and study completion dates: Jun 30, 2021 to Oct 30, 2021
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.
Trial Details
NCT Number NCT04543773
Lead Sponsor University of New Mexico
Collaborators: The Mind Research Network
Conditions Major Depressive Disorder
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov